Skip to main content

Table 1 Anti-cholinesterase activity of 1,2,3-triazole-dimethylaminoacryloyl-chromenone 10a-m
figure b

From: Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease

Entry

Ar

Product 10

AChEI IC50 (µM)

BuChEI IC50 (µM)

1

C6H5

10a

 > 100

34.41 ± 0.23

2

2-Me-C6H4

10b

 > 100

35.73 ± 0.21

3

4-Me-C6H4

10c

 > 100

 > 100

4

3-MeO-C6H4

10d

 > 100

23.44 ± 0.07

5

2-F-C6H4

10e

 > 100

 > 100

6

3-F-C6H4

10f

 > 100

59.58 ± 0.05

7

4-F-C6H4

10g

 > 100

 > 100

8

3,4-diF-C6H3

10h

 > 100

21.71 ± 0.57

9

2-Cl-C6H4

10i

 > 100

 > 100

10

4-Cl-C6H4

10j

 > 100

 > 100

11

2-Br-C6H4

10k

 > 100

 > 100

12

3-Br-C6H4

10l

 > 100

65.96 ± 0.004

13

4-Br-C6H4

10m

 > 100

 > 100

14

donepezil

 

0.079 ± 0.002

5.19 ± 0.38

  1. Data are expressed as mean ± SD (three independent experiments)